| Active, not recruiting | 3 | 222 | Europe, Canada, US, RoW | Adalimumab (ADA), Adalimumab, Humira, Conventional immunosuppression (CON), Azathioprine, Imuran , Cyclosporine, Methotrexate, Rheumatrex, Mycophenolate, CellCept, Cyclosporine, Sandimmune, Neoral, Tacrolimus, Prograf | JHSPH Center for Clinical Trials | Uveitis | 04/24 | 09/24 | | |